Clinical Trials Directory

Trials / Unknown

UnknownNCT03494478

Emotional Dysregulation in Adult ADHD.

Emotional Dysregulation and Cyclothymia in Adult Patients With ADHD: Cohort Follow-up of Patients in Two Referral Centers

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
University Hospital, Strasbourg, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Attention deficit disorder in adults with or without hyperactivity (ADHD) is a common disorder, affecting around 3% of the population. ADHD increases the risk of psychiatric disorders (mood disorders, sleep disorders, personality disorders, addictive behavior), risky behaviors, and vocational difficulties. Emotional dysregulation (ED) constitute a major hindrance in the daily life of subjects, with a great impact on the general functioning and the quality of life of the patients. The investigators want to determine the characteristics of patients with each type of ED (impulsivity, exacerbated emotional intensity, cyclothymia, borderline personality traits), and study the stability of these traits over time. Since circadian rhythms influence mood and circadian rhythms frequently occur in patients with ADHD, the investigators want to determine if there is a link between ED and instability in circadian rhythms. Finally, they would like to observe whether the ED evolves and according to whether or not treatment is taken

Conditions

Interventions

TypeNameDescription
OTHERNeuropsychological testingThe assessment will will be done at the time of the initial evaluation (undiagnosed / untreated patients), then at one year of follow-up
OTHERActimetryThe assessment will will be done at the time of the initial evaluation (undiagnosed / untreated patients), then at one year of follow-up.
OTHERSelf-questionnaires on emotional topicsThe assessment will will be done at the time of the initial evaluation (undiagnosed / untreated patients), then at one year of follow-up.

Timeline

Start date
2019-10-30
Primary completion
2023-06-01
Completion
2023-06-01
First posted
2018-04-11
Last updated
2023-04-18

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT03494478. Inclusion in this directory is not an endorsement.